Fifth Third Bancorp
ARLZ

Fifth Third Bancorp’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Fifth Third Bancorp’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100
Closed – – 2412
2018
Q2 		$0 Hold
100
– – ﹤0.01% 2447
2018
Q1 		$0 Hold
100
– – ﹤0.01% 2502
2017
Q4 		$0 Hold
100
– – ﹤0.01% 2440
2017
Q3 		$0 Hold
100
– – ﹤0.01% 2381
2017
Q2 		$0 Hold
100
– – ﹤0.01% 2350
2017
Q1 		$0 Hold
100
– – ﹤0.01% 2314
2016
Q4 		$0 Sell
100
-408
-80% -$1.94K ﹤0.01% 2396
2016
Q3 		$2K Buy
+508
New +$2.32K ﹤0.01% 2136

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Fifth Third Bancorp's ARLZ Position: Q3 2018 in Review

Fifth Third Bancorp sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 100 shares.

Fifth Third Bancorp first reported a position in ARLZ in Q3 2016 and held it in 8 quarters. The position peaked at $2K in Q3 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Fifth Third Bancorp reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Fifth Third Bancorp sold 100 Aralez Pharmaceuticals Inc. shares in Q3 2018.
  • Fifth Third Bancorp first reported a position in Aralez Pharmaceuticals Inc. in Q3 2016 and held it in 8 quarters.
  • Fifth Third Bancorp's Aralez Pharmaceuticals Inc. position peaked at $2K in Q3 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Fifth Third Bancorp's 13F filing for Q3 2018, filed 14 Nov 2018.